The Independent's journalism is supported by our readers. When you purchase through links on our site, we may earn commission.
'Chemical surgery' performed for first time on human embryos
Researchers removed the blood disorder beta-thalassemia
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
Scientists have carried out "chemical surgery" on human embryos to successfully remove a disease for the first time.
Researchers at Sun Yat-sen University in China used a technique called base editing to reprogramme a fault in a single base in our genetic code.
The experiments were carried out in laboratory-made embryos to remove the disease beta-thalassemia, an inherited blood disorder which can cause weakness, fatigue and lead to abnormal blood clots.
In the study, published in the journal Springer, the authors wrote: “β-Thalassemia is a global health issue, caused by mutations in the HBB gene.
“Among these mutations, HBB −28 (A>G) mutations is one of the three most common mutations in China and Southeast Asia patients with β-thalassemia.
“Correcting this mutation in human embryos may prevent the disease being passed onto future generations and cure anemia.”
The team edited one of the “fundamental building blocks of DNA” - the four bases adenine, cytosine, guanine and thymine (A, C, G and T), the BBC reported.
Combinations of these four bases essentially instruct how the human body works.
The blood disorder beta-thelassemia is caused by a change to a single base in the genetic code.
Using base editing, the researchers changed a G to an A to remove the blood disorder.
Base editing, pioneered by Harvard University Professor David Liu, is a new genome editing technology that allows the irreversible modification of genes within organisms.
He described the process as “chemical surgery”.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments